Nir Peled
Academic / Other · 2 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | First Line Therapy for Extensive SCLC Patients, Treated with Chemo+Keytruda Followed by Keytuda+Trodelvy NSCLC (non-small Cell Lung Cancer) | Phase 2 | 2024-12-24 |
| Not Yet Recruiting | A Pilot Study to Understand the Impact of Therapy With Tumour Treating Fields (TTFields) in NSCLC Non Small Cell Lung Cancer, EGFR Gene Mutation, Immune Checkpoint Inhibitor | N/A | 2023-01-20 |